Doctors' Publications

 

 

 

 

Dr Nagi Giumma Barakat MBBCh, MRCPCH, MSc epilepsy, CCST,FRCPCH
Consultant Paediatrician/ Hillingdon
Hospital

Honorary consultant/neurology department-Great Ormond Street Hospital
London - UK
E-mail: abuali@doctors.org.uk

   or   nbara5863@hotmail.com

I was born in Gharrian - Libya on 24th June 1958. My primary and secondary education was in Gharrian. I joined the Faculty of Medicine - University of
Garryounis, Benghazi-Libya in September 1976 and graduated in May 1984. I worked for 3 years in Gharrian General Hospital as Paediatric SHO. From 1987 till 1989 I worked as SHO and research assistant at University Children Hospital, Zurich, Switzerland.
In 1989 I married and moved to UK and got my full membership in paediatrics (MRCPCH) on February 1993. I worked as SHO for two years and 6 years as specialist registrar. I have special interest in Paediatric neurology and I got my master of sciences in epileptolgy from the University College of London in 1999. I finished my training in paediatrics and got my Certificate of completion of Specialist Training in February 2001. I am now working as consultant Paediatrician at Hillingdon
Hospital and Honorary consultant /neurology department at Great Ormond Street Hospital.
I published Five books to help the undergraduate and postgraduate students to pass their final exams. These books are mainly for students who are taking paediatrics as their specialty. Postgraduates who are preparing for Arabic board, Libyan board, MRCPCH UK/Ireland, Australian Board and Americans exams will find these books very useful. My first book (, "MCQs for the MRCP examination Part I Paediatrics") was published in 1994 and sold 4000 copies till today. My second book ("100 Data Interpretation Questions in Paediatrics, for MRCP/MRCPCH") was published in 1999 and sold 1500 copy till today. This book was recommended to all postgraduate students in Australia. My third book ("400 MCQs in paediatrics for MRCPCH/MRCP part I") which was published in August 2001."100 Grey Cases for MRCPCH" published February 2004 and get Through MRCPCH Part II: 125 question on clinical photographs" published September 2005. There will be two other EMQ and BOF questions for part one MRCPCH will be published by the end of this year. I am a member of the teaching staff at the University College Medical school of London. I teach regularly on Part I and Part II MRCPCH course at Guy's and St Thomas' Hospitals. I am taking part in writing and preparing materials for the Intranet assessment of medical students at University College Medical School of London. I am also member of Group alliance Global Internet Paediatric teaching group which will be launched September 2001. I like teaching and enjoy passing my knowledge and experience to my students.

I am keen to use my experience and knowledge to help my fellow country men and women who are taking exams in Paediatric medicine. Any one needs help or copy of my books, can reach me via my e-mail address.

  • Barakat N and O'Callaghan M, 1994, "MCQs for the MRCP examination Part I Paediatrics", 1st edition, Butterworth Heinemann, ISBN 0-7506-2029-3.
  • Barakat N "100 Data Interpretation Questions in Paediatrics, for MRCP/MRCPCH", 1999, 1st edition, The Royal Society of Medicine Press LTD, ISBN: 1-85315-405-9
  • Barakat N "400 MCQs in paediatrics for MRCPCH/MRCP part I". The Royal Society of Medicine Press LTD, July 2001, 1st edition
  • Barakat N "100 Grey Cases for MRCPCH" The Royal Society of Medicine press LTD. February 2004, 1st edition
  • Barakat N, Buchdhal R" Get Through MRCPCH Part II: 125 question on clinical photographs, The Royal Society of Medicine, September 2005, 1st Edition

 

 

 

Welcome to the Canadian Diabetes Association e-guidelines.

 Diabetes is a complex disease. Research and new technologies and therapeutics are rapidly expanding what we know about, and how we manage diabetes and its related complications. Given the burgeoning worldwide epidemic, healthcare professionals need to remain current in this ever-changing field.

This site is designed to help the user navigate the Canadian Diabetes Association’s 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada in a variety of ways. The Guidelines are designed to help translate clinical evidence about diabetes and its complications into information healthcare professionals can use in their everyday practice. The guidelines will also serve to inform healthcare policy as governments face a looming and costly diabetes epidemic. The e-guidelines are fully searchable, include relevant links, references, frequently asked questions and other resources intended to help answer your questions.

The Clinical Practice Guidelines were developed over two years by a volunteer Expert Committee and reviewed by 60 diabetes experts in Canada. The process included a broad-based review to ensure that the diabetes community at large had input into the document. These guidelines provide a useful reference to help translate clinical evidence into everyday practice and to help direct policy.

The individual chapters of the Clinical Practice Guidelines are available here as PDF files for download. Just click on the chapter title and the download will begin.
 



 



To unsubscribe from this group, send an email to:
Libyan-doc-unsubscribe@yahoogroups.com

 

 

American Journal of Hypertension
Volume 17, Issue 4
, April 2004, Pages 354-360

 

John W. Graves  and Sheldon G. Sheps

 

Doctors should stop measuring blood pressure in hypertensive patients

New York, NY - An editorial in the April 2004 issue of the American Journal of Hypertension argues that doctors should relinquish the responsibility for blood-pressure monitoring in their hypertensive patients, both because they're not very good at it and because it's a poor use of their expensive time.

Accurate BP measures are critical to the proper diagnosis and treatment of hypertension, but several studies have shown that in practice physicians often don't adhere to accepted standards when they take blood pressure, and their measurements are often compromised the "white-coat" effect, authors Drs John W Graves and Sheldon G Sheps (Mayo Clinic and Mayo Foundation, Rochester, MN) write.

"I would argue that it's a poor use of the most expensive person in the healthcare system to do that," Graves told heartwire. "I don't do it well, and I'm not going to get the right number, it doesn't compare to the trials, and I'm the most expensive one to do it. Why am I doing it?"

Applying the evidence

In all of the large hypertension trials since the early 1970s, including recent trials such as ALLHAT, STOP-2, and SYST-EUR, which provide the evidence base for the recent Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines, blood pressures were not measured by physicians but by nurses, "trained observers," or by validated ambulatory BP-monitoring devices, Graves and Sheps point out.

To ensure the applicability of trial results, it's critical that blood pressure be measured accurately, Graves told heartwire. "In hypertension, you're trying to establish whether the blood pressure is controlled and whether the patient needs to be on treatment, and there, small mistakes can make a big differenceit could throw somebody into the treatment category when they don't need it, or it can allow them to walk away undertreated."

 

Doctors don't like to hear anybody say they don't do something well.

 

 

A variety of studies have shown that measuring BP is not taught in a uniform way, and so, perhaps not surprisingly, doctors have performed poorly when studied in practice, they write. Instead, Graves and Sheps propose a system similar to that in diabetes, where a nurse-manager monitors patients. The physician would perform the initial assessment and draw up a treatment plan. The patient would then be followed by the nurse-manager and come back to the physician only if treatment proved ineffective.

Graves acknowledged that physicians have not received his message gratefully. "Doctors don't like to hear anybody say they don't do something well," he said wryly. Still, it takes up to 15 minutes to measure BP if proper procedures are followed: two measures in the right arm, one in the left, having the patient rest for five minutes before proceeding, and allowing at least a minute between measures. "I know they're not doing that in a 15-minute appointment."

He noted that new AHA guidelines on measuring blood pressure are in final draft and expected to be published later this year.

 

Abstract

Does evidence-based medicine suggest that physicians should not be measuring blood pressure in the hypertensive patient?

John W. Graves a, Corresponding Author Contact Information, E-mail  The Corresponding Authorand Sheldon G. Sheps

American Journal of Hypertension
Volume 17, Issue 4 , April 2004, Pages 354-360

The most common reason for an outpatient physician visit is for the diagnosis and treatment of hypertension. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC) VII, which is increasingly evidence-based, advises the clinician to use studies of the mean response and benefit derived from reduction in blood pressure (BP) from antihypertensive therapy and to translate this data into recommendations for the individual hypertensive patient. We believe that the increasingly aggressive approach to hypertension mandated by JNC VII calls into question the use of physician-measured BP. Ample evidence has shown that phycisians have not been adequately trained to measure BP and, therefore, rarely measure BP to the standards asked for by JNC VII or the American Heart Association (AHA) guidelines. In addition, the white coat effect dilutes the validity and usefulness of physician-measured BPs. Finally, in the evidenced-based studies used to derive the JNC VII guidelines, BPs were measured by nurses, other "trained observers," or automated devices, not physicians. Accurate BP measurement is critical to diagnosis and management of hypertension. We recommend, therefore, that for this purpose physicians should not measure BP themselves but should rely on BPs from well-trained and monitored observers or validated automated devices to improve the quality of care of the hypertensive patient.

 

Dr.Yousef S.I Alkhettaly

: ____________________________________________________________